Understanding and Treating Idiopathic Psychosis

In the Lizano laboratory, we focus on utilizing imaging, blood-based biomarker technology, and neuromodulation to better characterize and offer potential evidence-based interventions for serious mental illness, specifically idiopathic psychotic disorders.

We actively develop retinal and brain imaging processing tools and blood-based biomarker subtyping that are utilized in collaboration with Massachusetts Eye and Ear, UT Southwestern Medical Center, University of Minnesota, University of Pittsburgh, and Johns Hopkins University. Work in the Lizano laboratory also involves in vivo and ex vivo techniques to examine inflammation-mediated disruption of the blood brain barrier in psychosis. Additionally, we have extended our work to use non-invasive neuromodulation to target a causal brain region associated with visual hallucinations.